Loss of Kat2a enhances transcriptional noise and depletes acute myeloid leukemia stem-like cells
Ana Filipa Domingues,
Rashmi Kulkarni,
George Giotopoulos,
Shikha Gupta,
Laura Vinnenberg,
Liliana Arede,
Elena Foerner,
Mitra Khalili,
Rita Romano Adao,
Ayona Johns,
Shengjiang Tan,
Keti Zeka,
Brian J Huntly,
Sudhakaran Prabakaran,
Cristina Pina
Affiliations
Ana Filipa Domingues
Department of Haematology, University of Cambridge, NHS-BT Blood Donor Centre, Cambridge, United Kingdom
Rashmi Kulkarni
Department of Haematology, University of Cambridge, NHS-BT Blood Donor Centre, Cambridge, United Kingdom
George Giotopoulos
Department of Haematology, University of Cambridge, Cambridge Institute for Medical Research, Cambridge, United Kingdom; Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute, Cambridge, United Kingdom
Shikha Gupta
Department of Haematology, University of Cambridge, NHS-BT Blood Donor Centre, Cambridge, United Kingdom; Department of Genetics, University of Cambridge, Cambridge, United Kingdom
Laura Vinnenberg
Department of Haematology, University of Cambridge, NHS-BT Blood Donor Centre, Cambridge, United Kingdom
Liliana Arede
Department of Haematology, University of Cambridge, NHS-BT Blood Donor Centre, Cambridge, United Kingdom; Department of Genetics, University of Cambridge, Cambridge, United Kingdom
Elena Foerner
Department of Haematology, University of Cambridge, NHS-BT Blood Donor Centre, Cambridge, United Kingdom
Mitra Khalili
Department of Haematology, University of Cambridge, NHS-BT Blood Donor Centre, Cambridge, United Kingdom; Department of Medical Genetics and Molecular Medicine, School of Medicine, Zanjan University of Medical Sciences (ZUMS), Zanjan, Islamic Republic of Iran
Rita Romano Adao
Department of Haematology, University of Cambridge, NHS-BT Blood Donor Centre, Cambridge, United Kingdom
Ayona Johns
Division of Biosciences, College of Health and Life Sciences, Brunel University London, Uxbridge, United Kingdom
Shengjiang Tan
Department of Haematology, University of Cambridge, Cambridge Institute for Medical Research, Cambridge, United Kingdom
Keti Zeka
Department of Haematology, University of Cambridge, NHS-BT Blood Donor Centre, Cambridge, United Kingdom; Department of Genetics, University of Cambridge, Cambridge, United Kingdom
Brian J Huntly
Department of Haematology, University of Cambridge, Cambridge Institute for Medical Research, Cambridge, United Kingdom; Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute, Cambridge, United Kingdom
Sudhakaran Prabakaran
Department of Genetics, University of Cambridge, Cambridge, United Kingdom; Department of Biology, IISER, Pune, India
Department of Genetics, University of Cambridge, Cambridge, United Kingdom; Division of Biosciences, College of Health and Life Sciences, Brunel University London, Uxbridge, United Kingdom
Acute Myeloid Leukemia (AML) is an aggressive hematological malignancy with abnormal progenitor self-renewal and defective white blood cell differentiation. Its pathogenesis comprises subversion of transcriptional regulation, through mutation and by hijacking normal chromatin regulation. Kat2a is a histone acetyltransferase central to promoter activity, that we recently associated with stability of pluripotency networks, and identified as a genetic vulnerability in AML. Through combined chromatin profiling and single-cell transcriptomics of a conditional knockout mouse, we demonstrate that Kat2a contributes to leukemia propagation through preservation of leukemia stem-like cells. Kat2a loss impacts transcription factor binding and reduces transcriptional burst frequency in a subset of gene promoters, generating enhanced variability of transcript levels. Destabilization of target programs shifts leukemia cell fate out of self-renewal into differentiation. We propose that control of transcriptional variability is central to leukemia stem-like cell propagation, and establish a paradigm exploitable in different tumors and distinct stages of cancer evolution.